Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Clearside Biomedi (CLSD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 38,724
  • Shares Outstanding, K 37,596
  • Annual Sales, $ 30 K
  • Annual Income, $ -82,820 K
  • 60-Month Beta -0.80
  • Price/Sales 1,303.33
  • Price/Cash Flow N/A
  • Price/Book 2.48

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate -0.37
  • Number of Estimates 4
  • High Estimate -0.26
  • Low Estimate -0.46
  • Prior Year -0.65
  • Growth Rate Est. (year over year) +43.08%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.95 +11.05%
on 06/12/19
1.24 -14.92%
on 05/20/19
-0.17 (-13.52%)
since 05/17/19
3-Month
0.95 +11.05%
on 06/12/19
1.58 -33.23%
on 03/22/19
-0.36 (-25.18%)
since 03/18/19
52-Week
0.95 +11.05%
on 06/12/19
11.24 -90.62%
on 07/06/18
-9.53 (-90.04%)
since 06/18/18

Most Recent Stories

More News
Clearside Biomedical to Present at the JMP Securities Life Sciences Conference

Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye diseases, announced today that Thomas...

CLSD : 1.05 (+2.43%)
Clearside Biomedical to Present at the UBS Global Healthcare Conference

­­

CLSD : 1.05 (+2.43%)
Clearside Biomedical Announces First Quarter 2019 Financial Results and Provides Corporate Update

- Scientific Presentations Support Broad Applicability of Clearside Delivery Platform -

CLSD : 1.05 (+2.43%)
Clearside Biomedical's Suprachoroidal Space Injection Platform Featured at Multiple Ophthalmology and Gene Therapy Medical Meetings

- SCS injection platform continues to be well-received by the medical community -

CLSD : 1.05 (+2.43%)
Outlook Therapeutics Announces Addition of Jennifer M. Kissner, Ph.D. as Senior Vice President, Clinical Development

Outlook Therapeutics, Inc. (NASDAQ: OTLK) (the "Company"), a clinical-stage biopharmaceutical company focused on developing its lead clinical program, ONS-5010, a proprietary ophthalmic bevacizumab product...

OTLK : 2.07 (-4.17%)
CLSD : 1.05 (+2.43%)
Clearside Biomedical to Report First Quarter 2019 Financial Results and Provide Corporate Update on Wednesday, May 8, 2019

Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye diseases, announced today that its...

CLSD : 1.05 (+2.43%)
Clearside Biomedical Announces Multiple Presentations on its Suprachoroidal Space(R) Injection Platform at Upcoming Medical Meetings

Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye diseases, announced today that multiple...

CLSD : 1.05 (+2.43%)
New Research: Key Drivers of Growth for FedEx, Clearside Biomedical, Aaron's, Lumber Liquidators, Timken, and Novanta -- Factors of Influence, Major Initiatives and Sustained Production

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of FedEx Corporation (NYSE:FDX),...

LL : 10.87 (+6.67%)
CLSD : 1.05 (+2.43%)
TKR : 48.29 (+3.07%)
FDX : 166.34 (+1.60%)
NOVT : 89.94 (+3.74%)
AAN : 60.51 (-0.64%)
Clearside Biomedical Appoints Dr. George Lasezkay as Interim CEO

Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye diseases, announced today that its...

CLSD : 1.05 (+2.43%)
Clearside Biomedical to Present at the 18th Annual Needham Healthcare Conference

Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye diseases, announced today that Daniel...

CLSD : 1.05 (+2.43%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade CLSD with:

Business Summary

Clearside Biomedical, Inc. is a biopharmaceutical company is engaged in developing first-in-class drug therapies to treat blinding diseases of the eye using Clearside proprietary suprachoroidal space(TM) microinjector. Its products include CLS-1001 for the treatment of macular edema associated with non-infectious...

See More

Key Turning Points

2nd Resistance Point 1.09
1st Resistance Point 1.06
Last Price 1.05
1st Support Level 1.01
2nd Support Level 0.99

See More

52-Week High 11.24
Fibonacci 61.8% 7.31
Fibonacci 50% 6.10
Fibonacci 38.2% 4.88
Last Price 1.05
52-Week Low 0.95

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar